⌘K

Login Start Free

Home/Filings/4/0000899243-20-027445

4//SEC Filing

DOWNEY BRUCE 4

Accession 0000899243-20-027445

CIK 0001662579other

View on SEC.gov Company Profile

Filed

Oct 4, 8:00 PM ET

Accepted

Oct 5, 9:00 PM ET

Size

5.2 KB

Accession

0000899243-20-027445

Insider Transaction Report

Form 4

Period: 2020-10-01

C4 Therapeutics, Inc.CCCC

Director

Transactions

Award
Stock Option (Right to Buy)
2020-10-01+17,786→ 17,786 total
Exercise: $19.00Exp: 2030-09-30→ Common Stock (17,786 underlying)

Footnotes (1)

[F1]This option shall vest and become exercisable upon the earlier to occur of (i) October 1, 2021, and (ii) the next annual meeting of the Issuer's stockholders.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

C4 Therapeutics, Inc.

CIK 0001662579

Entity typeother

Related Parties

1

filerCIK 0001237257

Filing Metadata

Form type: 4
Filed: Oct 4, 8:00 PM ET
Accepted: Oct 5, 9:00 PM ET
Size: 5.2 KB

View on SEC.gov